AREVA ( back to the Home Page )

Log in
This page allows you to manage all your electronic subscriptions on this site.
Register
Suscribe to the AREVA dashboard give you an access to newsletters, news, and email alerts from the Dialogue section...
FRENDE
Media Center

Clinical trials

AREVA Med is dedicated to improving the lives of cancer patients by developing new methods for producing medical-grade 212Pb, a promising isotope for combating cancer and other diseases.
Our goal is to develop 212Pb radiolabeled biopharmaceuticals, extend survival, and improve the overall quality of life of patients suffering from cancer. Our current Phase I clinical trial is designed for patients with HER-2 expressing carcinoma (e.g., ovarian, pancreatic, colon, gastric, or breast), mainly confined to the abdominal cavity.

http://clinicaltrials.gov/ct2/show/study/NCT01384253 Pipe-line clinical trials



For Patients:

decorative

Phase I clinical trials are a crucial part of developing new treatments; during this phase, patients volunteer to receive a new medicine and to be observed for its effects.

AREVA Med posts information for its ongoing clinical trial on the National Institutes of Health (NIH) website, ClinicalTrials.gov.  To learn more about the AREVA Med-sponsored clinical trial, please visit  the ClinicalTrial website. The clinical site conducting the trial may also be contacted to obtain additional information on our study.

Patients interested in participating in this clinical trial should discuss this option with their physicians.  Please contact the University of Alabama at Birmingham directly for enrollment information:

Ronda Carlisle, RN, BSN, OCN
University Of Alabama at Birmingham
Birmingham, Alabama 35233
(205) 975-2511
ronda.carlisle@ccc.uab.edu  

For Physicians:

decorative

AREVA Med posts protocol information for its ongoing clinical trial on the National Institutes of Health (NIH) website, ClinicalTrials.gov.
To learn more about the AREVA Med-sponsored clinical trial, please visit ClinicalTrials.gov web site.

To contact our team, please email Alison Bedford: alison.bedford@areva.com

For more information on the organizations involved in our study, please visit the following websites: